<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911435724</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911435724</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Metastatic Mammary Carcinoma With DCIS-Like Morphology</article-title>
<subtitle>A Report of Two Cases</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Coyne</surname><given-names>John</given-names></name>
<degrees>FRCPath</degrees>
<xref ref-type="aff" rid="aff1-1066896911435724">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911435724"><label>1</label>Royal Liverpool Hospital, Liverpool, UK</aff>
<author-notes>
<corresp id="corresp1-1066896911435724">John Coyne, Royal Liverpool Hospital, Prescott Street, Liverpool L7 8XP, UK Email: <email>johnnycoyne@doctors.org.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>485</fpage>
<lpage>487</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract><p>Two cases of breast carcinoma with lymph node metastases are presented. In each case the metastases demonstrated the unusual phenomenon of resembling either cribriform or comedo DCIS. Furthermore both cases had the additional rare feature of demonstrable lymphatic involvement by DCIS-like carcinoma.</p></abstract>
<kwd-group>
<kwd>carcinoma</kwd>
<kwd>DCIS-like</kwd>
<kwd>metastatic</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Metastatic breast carcinoma in lymph nodes may mimic all the morphological forms of intraduct carcinoma.<sup><xref ref-type="bibr" rid="bibr1-1066896911435724">1</xref><xref ref-type="bibr" rid="bibr2-1066896911435724"/><xref ref-type="bibr" rid="bibr3-1066896911435724"/><xref ref-type="bibr" rid="bibr4-1066896911435724"/><xref ref-type="bibr" rid="bibr5-1066896911435724"/>-<xref ref-type="bibr" rid="bibr6-1066896911435724">6</xref></sup> It was previously postulated that this phenomenon represented a reversal to a noninvasive phenotype called revertant ductal carcinoma in situ (DCIS). Although this concept has largely been disproved by immunohistochemistry, an additional morphological feature is presented in this report, providing further confirmation that it is a morphological variant of invasive breast carcinoma.</p>
<sec id="section1-1066896911435724">
<title>Case1</title>
<p>A 42-year-old female presented with a lump in her breast. Microscopic examination showed invasive ductal carcinoma grade 2 and areas resembling high-grade cribriform and comedo DCIS. Six of 8 lymph nodes showed a mixture of invasive ductal carcinoma and metastatic carcinoma with DCIS-like features (<xref ref-type="fig" rid="fig1-1066896911435724">Figure 1</xref>). In addition, a focus resembling high-grade comedo DCIS was present in an adjacent afferent lymphatic vessel (<xref ref-type="fig" rid="fig2-1066896911435724">Figure 2</xref>). Immunohistochemistry on the primary breast carcinoma displayed positive staining for myoepithelial cells around most but not all foci of DCIS with SMA and calponin but only focal positivity with p63. CD10 and cytokeratin 14 were nonreactive. All markers were negative in the lymph node metastases.</p>
<fig id="fig1-1066896911435724" position="float">
<label>Figure 1.</label>
<caption>
<p>Metastatic breast carcinoma resembling DCIS</p>
</caption>
<graphic xlink:href="10.1177_1066896911435724-fig1.tif"/>
</fig>
<fig id="fig2-1066896911435724" position="float">
<label>Figure 2.</label>
<caption>
<p>Afferent vessel (adjacent to involved lymph node depicted in <xref ref-type="fig" rid="fig1-1066896911435724">Figure 1</xref>) containing DCIS-like mammary carcinoma</p>
</caption>
<graphic xlink:href="10.1177_1066896911435724-fig2.tif"/>
</fig>
</sec>
<sec id="section2-1066896911435724">
<title>Case 2</title>
<p>A 60-year-old female presented with a breast lump. Microscopic examination showed an infiltrating ductal carcinoma grade 1, which in places was cribriform in appearance and with interspersed foci of low-grade cribriform DCIS. Several foci of intravascular-lymphatic permeation by cribriform carcinoma were also present (<xref ref-type="fig" rid="fig3-1066896911435724">Figure 3</xref>). Four of 6 lymph nodes showed a mixture of grade 1 ductal carcinoma and cribriform carcinoma resembling DCIS (<xref ref-type="fig" rid="fig4-1066896911435724">Figure 4</xref>). Immunohistochemistry showed positively staining myoepithelial cells with SMA, calponin, and p63 around most of the foci of DCIS in the breast carcinoma. A few foci showed absent, partial, or attenuated reactivity. CD10 and cytokeratin 14 were negative. The lymph nodes were negative for all markers.</p>
<fig id="fig3-1066896911435724" position="float">
<label>Figure 3.</label>
<caption>
<p>Lymph node replaced by metastatic mammary carcinoma resembling cribriform DCIS</p>
</caption>
<graphic xlink:href="10.1177_1066896911435724-fig3.tif"/>
</fig>
<fig id="fig4-1066896911435724" position="float">
<label>Figure 4.</label>
<caption>
<p>Invasive breast carcinoma with foci of vascular invasion resembling cribriform DCIS</p>
</caption>
<graphic xlink:href="10.1177_1066896911435724-fig4.tif"/>
</fig>
</sec>
<sec id="section3-1066896911435724">
<title>Discussion</title>
<p>In 1980, Cowen described an intraduct pattern of metastatic breast carcinoma in a lymph node metastasis; similar foci were present in the primary breast carcinoma.<sup><xref ref-type="bibr" rid="bibr1-1066896911435724">1</xref></sup> Cowen suggested that the presence of a basement membrane was not proof that they were not invasive carcinoma and that the appearances merely represented a morphological pattern of invasive cancer. In 1984, Cowen and Bates published a study on the significance of an intraduct appearance in breast cancer.<sup><xref ref-type="bibr" rid="bibr2-1066896911435724">2</xref></sup> They reported that, of the metastases showing an intraduct pattern, 43% had both an “intraduct” and invasive carcinoma in the primary breast tumor, whereas 37% showed only an invasive pattern. In 1997, Barsky et al, in a study of 200 cases of metastatic breast carcinoma, cited an incidence of DCIS morphology in the lymph node metastases of 21%.<sup><xref ref-type="bibr" rid="bibr4-1066896911435724">4</xref></sup> In addition, Barsky et al described complete morphological concordance between the primary and the lymph node metastases and described consistently a surrounding basement membrane but no myoepithelial cells with immunohistochemistry.<sup><xref ref-type="bibr" rid="bibr4-1066896911435724">4</xref></sup> Barsky et al concluded that this appearance represented a reversion to a noninvasive morphological phenotype.<sup><xref ref-type="bibr" rid="bibr4-1066896911435724">4</xref></sup> However, Lee et al in 1995 reported a case of metastatic breast carcinoma that had the appearance of micropapillary ductal carcinoma in situ.<sup><xref ref-type="bibr" rid="bibr3-1066896911435724">3</xref></sup> These areas, in both the primary tumor and in the metastasis, had a surrounding basement membrane but no myoepithelial cells with immunohistochemical examination. Furthermore, Kordek later described 2 cases of such metastatic breast carcinomas.<sup><xref ref-type="bibr" rid="bibr5-1066896911435724">5</xref></sup> The first case was an infiltrating ductal carcinoma without an intraductal component and with a metastasis resembling micropapillary intraductal carcinoma. The second case was an invasive ductal carcinoma with a component resembling DCIS of comedo type; 2 lymph node metastases resembled comedo DCIS. In contrast to the observations of Barsky et al, among whose cases were found no DCIS-like structures with basement membranes lacking myoepithelial cells, Kordek found an absence of myoepithelial cells in both the metastatic DCIS-like foci and also surrounding the comedo intraductal-like component in the primary carcinoma of case 2. In addition, Kordek cited an incidence of DCIS-like metastases of approximately 1.5%. With regard to the 2 cases reported herein, myoepithelial cells were present around some but not all the DCIS-like areas in the primary tumors and absent around the metastatic DCIS-like foci. This is in agreement with Kordek who interprets both the metastatic and in situ–like lesions as morphological forms of invasive carcinoma. Moreover, these 2 cases reported clearly demonstrate this morphologically invasive pattern metastasizing in flagranti as in situ patterns and confirming the original observations of Dr Cowen.<sup><xref ref-type="bibr" rid="bibr1-1066896911435724">1</xref></sup></p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911435724">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cowen</surname><given-names>PN</given-names></name>
</person-group>. <article-title>Recognition of intraduct mammary carcinoma</article-title>. <source>J Clin Pathol</source>. <year>1980</year>;<volume>33</volume>:<fpage>797</fpage>.</citation>
</ref>
<ref id="bibr2-1066896911435724">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cowen</surname><given-names>PN</given-names></name>
<name><surname>Bates</surname><given-names>C</given-names></name>
</person-group>. <article-title>The significance of intraduct appearances in breast cancer</article-title>. <source>Clin Oncol</source>. <year>1984</year>;<volume>10</volume>:<fpage>67</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911435724">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>AHS</given-names></name>
<name><surname>Telfer</surname><given-names>TP</given-names></name>
<name><surname>Millis</surname><given-names>RR</given-names></name>
</person-group>. <article-title>Metastatic breast carcinoma with appearance resembling micropapillary ductal carcinoma in-situ</article-title>. <source>J Clin Pathol</source>. <year>1995</year>;<volume>48</volume>:<fpage>380</fpage>-<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911435724">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barsky</surname><given-names>SH</given-names></name>
<name><surname>Doberneck</surname><given-names>SA</given-names></name>
<name><surname>Sternlicht</surname><given-names>MD</given-names></name>
<name><surname>Grossman</surname><given-names>DA</given-names></name>
<name><surname>Love</surname><given-names>SM</given-names></name>
</person-group>. <article-title>“Revertant” DCIS in human axillary breast carcinoma metastases</article-title>. <source>J Pathol</source>. <year>1997</year>;<volume>183</volume>:<fpage>188</fpage>-<lpage>194</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911435724">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kordek</surname><given-names>R</given-names></name>
</person-group>. <article-title>Ductal carcinoma in-situ-like structures in metastatic breast carcinoma</article-title>. <source>Pathol Res Pract</source>. <year>2005</year>;<volume>200</volume>:<fpage>831</fpage>-<lpage>834</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911435724">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cserni</surname><given-names>G</given-names></name>
</person-group>. <article-title>“Revertant” mammary solid papillary carcinoma in lymph node metastasis</article-title>. <source>Pathol Oncol Res</source>. <year>2002</year>;<volume>8</volume>:<fpage>74</fpage>-<lpage>77</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>